Back
Grace Therapeutics Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52
GRCE
Grace Therapeutics Inc.
Last Price:
$3.26
Seasonality Move:
-16.02%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GRCE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Grace Therapeutics Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.14 | Buy |
| 20-day SMA: | 3.11 | Buy |
| 50-day SMA: | 3.08 | Buy |
| 200-day SMA: | 3.08 | Buy |
| 8-day EMA: | 3.06 | Buy |
| 20-day EMA: | 2.33 | Buy |
| 50-day EMA: | 1.32 | Buy |
| 200-day EMA: | 0.4 | Buy |
Grace Therapeutics Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.79 | Buy |
| Relative Strength Index (14 RSI): | 56.26 | Buy |
| Chaikin Money Flow: | 41650 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.98 - 3.32) | Buy |
| Bollinger Bands (100): | (2.41 - 3.19) | Buy |
Grace Therapeutics Inc. Technical Analysis
| Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Grace Therapeutics Inc. Stock
Is Grace Therapeutics Inc. Stock a Buy?
-
Grace Therapeutics Inc. share price is 3.26 while GRCE 8-day simple moving average is 3.14, which is a Buy signal.
-
The stock price of GRCE is 3.26 while Grace Therapeutics Inc. 20-day SMA is 3.11, which makes it a Buy.
-
Grace Therapeutics Inc. 50-day simple moving average is 3.08 while GRCE share price is 3.26, making it a Buy technically.
-
GRCE stock price is 3.26 and Grace Therapeutics Inc. 200-day simple moving average is 3.08, creating a Buy signal.
GRCE Technical Analysis vs Fundamental Analysis
Buy
52
Grace Therapeutics Inc. (GRCE)
is a Buy
Is Grace Therapeutics Inc. a Buy or a Sell?
-
Grace Therapeutics Inc. stock is rated a BuyThe current Grace Therapeutics Inc. [GRCE] share price is $3.26. The Score for GRCE is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Grace Therapeutics Inc. Stock Info
Market Cap:
45.1M
Price in USD:
3.26
Share Volume:
78.7K
Grace Therapeutics Inc. 52-Week Range
52-Week High:
4.97
52-Week Low:
1.75
Buy
52
Grace Therapeutics Inc. (GRCE)
is a Buy
Grace Therapeutics Inc. Share Price Forecast
-
What is the Grace Therapeutics Inc. stock price today?The Grace Therapeutics Inc. stock price is 3.26 USD today.
-
Will GRCE stock go up or go down?Grace Therapeutics Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Grace Therapeutics Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Grace Therapeutics Inc. is not overvalued.
Is Grace Therapeutics Inc. Stock a Buy?
-
Grace Therapeutics Inc. share price is 3.26 while GRCE 8-day exponential moving average is 3.06, which is a Buy signal.
-
The stock price of GRCE is 3.26 while Grace Therapeutics Inc. 20-day EMA is 2.33, which makes it a Buy.
-
Grace Therapeutics Inc. 50-day exponential moving average is 1.32 while GRCE share price is 3.26, making it a Buy technically.
-
GRCE stock price is 3.26 and Grace Therapeutics Inc. 200-day simple moving average is 0.40, creating a Buy signal.
Fundamental Analysis of Grace Therapeutics Inc.
Is Grace Therapeutics Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.05 per share, an increase this year of $0.23 per share, and an increase next year of $0.30 per share.
Technical Analysis of Grace Therapeutics Inc.
Should I short Grace Therapeutics Inc. stock?
-
GRCE Moving Average Covergence Divergence (MACD) indicator is 0.79, suggesting Grace Therapeutics Inc. is a Buy
-
Grace Therapeutics Inc. Relative Strength Index (RSI) is 56.26, which suggest Grace Therapeutics Inc. is overbought
-
The Bollinger Bands (25) for Grace Therapeutics Inc. is (2.98 - 3.32), which suggest Grace Therapeutics Inc. is a Buy
-
The Bollinger Bands (100) for Grace Therapeutics Inc. is (2.41 - 3.19), which suggest Grace Therapeutics Inc. is a Buy
* Grace Therapeutics Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.